Tocqueville Asset Management L.P. lowered its position in shares of Agilent Technologies Inc (NYSE:A) by 0.5% during the 3rd quarter, HoldingsChannel reports. The firm owned 213,237 shares of the medical research company’s stock after selling 1,123 shares during the period. Tocqueville Asset Management L.P.’s holdings in Agilent Technologies were worth $15,042,000 at the end of the most recent reporting period.

A number of other large investors have also recently modified their holdings of A. OppenheimerFunds Inc. lifted its holdings in shares of Agilent Technologies by 64.0% in the second quarter. OppenheimerFunds Inc. now owns 7,636,621 shares of the medical research company’s stock worth $472,248,000 after buying an additional 2,980,216 shares in the last quarter. American Century Companies Inc. lifted its holdings in shares of Agilent Technologies by 30.3% in the second quarter. American Century Companies Inc. now owns 4,585,162 shares of the medical research company’s stock worth $283,546,000 after buying an additional 1,065,877 shares in the last quarter. Marshall Wace LLP lifted its holdings in shares of Agilent Technologies by 1,831.9% in the second quarter. Marshall Wace LLP now owns 981,142 shares of the medical research company’s stock worth $60,674,000 after buying an additional 930,356 shares in the last quarter. Pictet Asset Management Ltd. lifted its holdings in shares of Agilent Technologies by 26.9% in the third quarter. Pictet Asset Management Ltd. now owns 2,350,857 shares of the medical research company’s stock worth $165,829,000 after buying an additional 498,430 shares in the last quarter. Finally, Morgan Stanley lifted its holdings in shares of Agilent Technologies by 67.6% in the second quarter. Morgan Stanley now owns 1,227,627 shares of the medical research company’s stock worth $75,917,000 after buying an additional 495,160 shares in the last quarter.

Shares of A opened at $71.42 on Thursday. Agilent Technologies Inc has a fifty-two week low of $60.42 and a fifty-two week high of $75.11. The firm has a market capitalization of $23.24 billion, a P/E ratio of 25.54, a price-to-earnings-growth ratio of 2.04 and a beta of 1.36. The company has a current ratio of 3.29, a quick ratio of 2.74 and a debt-to-equity ratio of 0.39.

Agilent Technologies (NYSE:A) last announced its quarterly earnings results on Monday, November 19th. The medical research company reported $0.81 earnings per share for the quarter, topping the consensus estimate of $0.74 by $0.07. Agilent Technologies had a net margin of 6.43% and a return on equity of 19.84%. The company had revenue of $1.29 billion for the quarter, compared to analysts’ expectations of $1.26 billion. During the same quarter in the previous year, the business posted $0.67 earnings per share. Agilent Technologies’s quarterly revenue was up 8.8% on a year-over-year basis. As a group, analysts anticipate that Agilent Technologies Inc will post 3.04 EPS for the current year.

Agilent Technologies declared that its board has authorized a share buyback plan on Monday, November 19th that permits the company to buyback $1.75 billion in outstanding shares. This buyback authorization permits the medical research company to buy up to 8.8% of its stock through open market purchases. Stock buyback plans are usually a sign that the company’s leadership believes its stock is undervalued.

The firm also recently declared a quarterly dividend, which will be paid on Wednesday, January 23rd. Investors of record on Monday, December 31st will be given a $0.164 dividend. This represents a $0.66 annualized dividend and a yield of 0.92%. The ex-dividend date of this dividend is Friday, December 28th. This is a boost from Agilent Technologies’s previous quarterly dividend of $0.15. Agilent Technologies’s payout ratio is currently 21.51%.

In other Agilent Technologies news, CEO Michael R. Mcmullen sold 15,923 shares of the business’s stock in a transaction on Monday, December 3rd. The shares were sold at an average price of $73.20, for a total transaction of $1,165,563.60. Following the transaction, the chief executive officer now owns 492,546 shares in the company, valued at $36,054,367.20. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink. Also, insider Dominique Grau sold 8,902 shares of the business’s stock in a transaction on Monday, December 3rd. The shares were sold at an average price of $74.00, for a total transaction of $658,748.00. Following the transaction, the insider now owns 103,387 shares in the company, valued at approximately $7,650,638. The disclosure for this sale can be found here. Insiders sold 34,683 shares of company stock worth $2,499,491 in the last 90 days.

Several equities analysts have recently commented on A shares. Goldman Sachs Group raised shares of Agilent Technologies from a “buy” rating to a “conviction-buy” rating in a report on Monday, September 17th. ValuEngine downgraded shares of Agilent Technologies from a “buy” rating to a “hold” rating in a report on Tuesday, October 23rd. Morgan Stanley boosted their target price on shares of Agilent Technologies from $86.00 to $89.00 and gave the stock an “overweight” rating in a report on Tuesday, November 20th. Cleveland Research cut shares of Agilent Technologies from a “buy” rating to a “neutral” rating in a research report on Monday, November 12th. Finally, Deutsche Bank boosted their price target on shares of Agilent Technologies from $77.00 to $80.00 and gave the stock a “buy” rating in a research report on Wednesday, August 15th. Two research analysts have rated the stock with a hold rating and nine have issued a buy rating to the company’s stock. The stock has a consensus rating of “Buy” and an average price target of $78.75.

COPYRIGHT VIOLATION NOTICE: This piece was posted by Watch List News and is owned by of Watch List News. If you are reading this piece on another website, it was stolen and republished in violation of United States & international copyright legislation. The legal version of this piece can be accessed at https://www.watchlistnews.com/tocqueville-asset-management-l-p-has-15-04-million-holdings-in-agilent-technologies-inc-a/2665232.html.

Agilent Technologies Profile

Agilent Technologies, Inc provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. It operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; microfluidics based automated electrophoresis products; cell analysis plate based assays; laboratory software and informatics systems; laboratory automation; dissolution testing; vacuum pumps; and measurement technologies.

Recommended Story: Call Option

Want to see what other hedge funds are holding A? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Agilent Technologies Inc (NYSE:A).

Institutional Ownership by Quarter for Agilent Technologies (NYSE:A)

Receive News & Ratings for Agilent Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Agilent Technologies and related companies with MarketBeat.com's FREE daily email newsletter.